NIKA · Nika Pharmaceuticals, Inc · Analyst Estimates
$0.35
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 10, 2026
Market Cap
$431.19M
Shares
1.05B
Volume · Oct 22
650
Avg daily vol (7 sessions)
1263
Analyst Estimates
Compare analyst forecasts for Nika Pharmaceuticals, Inc across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Published by the company
No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.
No published consensus found
No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.